Αναζήτηση

σε πρόσθεσε στο άλλο

2025-12-10 09:01:06 -

The Global Tocilizumab Market Size Was Valued at USD 81.19 Million in 2023 and is Projected to Reach USD 228.96 Billion by 2032

The Global Tocilizumab Market Size Was Valued at USD 81.19 Million in 2023 and is Projected to Reach USD 228.96 Billion by 2032, Growing at a CAGR of 12.20%. Tocilizumab (marketed primarily as Actemra) is a breakthrough therapeutic agent a humanized monoclonal antibody specifically designed to target the interleukin-6 (IL-6) receptor. By binding to this receptor, Tocilizumab effectively blocks...

0 Σχόλια 0 Μοιράστηκε 745 Views 0 Προεπισκόπηση